NEW YORK (GenomeWeb) – InstantLabs Medical Diagnostics announced yesterday that it has sold a controlling equity stake to private investment firm Angeon Group.

In connection with the sale, the company said it would change its name to InstantLabs. Angeon CEO Joseph Gargan will serve as CEO of InstantLabs and join its board, while InstantLabs Director of R&D Neil Sharma has been promoted to president.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.